amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights#656713Zenodo (CERN)
• Living with Amyotrophic Lateral Sclerosis: Exploring what matters to patients and caregivers through their experiences.#678216NCBI PubMed Central
• Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial#812142ClinicalTrials.gov
• A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study#846869ClinicalTrials.gov
• A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS#852751ClinicalTrials.gov
• Longitudinal Study of Outcomes Measures in ALS Trials#855601ClinicalTrials.gov
• Impact of Nuedexta on Bulbar Physiology and Function in ALS#905397ClinicalTrials.gov
• MAD-SLA Project Dataset Metadata and Documentation#990684Zenodo (CERN)
• AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis#845203ClinicalTrials.gov
• An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis#970063ClinicalTrials.gov
• Correlations of clinical and cognitive characteristics with neuroimaging in patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) / Annaliis Lehto ; Gutachter: Johannes Prudlo, Stefan Teipel, Peter Bede#624006Deutsche Nationalbibliothek
• The burden of care: Health and wellbeing of informal caregivers of people with amyotrophic lateral sclerosis.#182598NCBI PubMed Central
• Quantifying motor unit loss prior to functional impairment in muscles affected by amyotrophic lateral sclerosis.#360658NCBI PubMed Central
• Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis#384797HAL (France)
• The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosis#384821HAL (France)
• Mitch Albom's Tuesdays with Morrie#654354Open Library
• Recent Advancements in Drug Delivery Across the Blood-Brain Barrier in Amyotrophic Lateral Sclerosis (ALS).#785562NCBI PubMed Central
• To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers#840217ClinicalTrials.gov
• Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)#842218ClinicalTrials.gov
• EIM Via the Myolex mScan as an ALS Biomarker#860271ClinicalTrials.gov
• Mitochondrial Functions and Oxidative Stress in ALS Patients#873457ClinicalTrials.gov
• A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV#873594ClinicalTrials.gov
• Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis#883328ClinicalTrials.gov
• CNS10-NPC-GDNF for the Treatment of ALS#899674ClinicalTrials.gov
• Italian Validation of the Beaumont Behavioural Inventory (BBI)#912411ClinicalTrials.gov
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS#917122ClinicalTrials.gov
• Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis#923132IRIS
• White matter changes in reward circuits of amyotrophic lateral sclerosis: a fixel-based study of appetite loss.#159699NCBI PubMed Central
• Salivary dim-light melatonin onset in early Amyotrophic Lateral Sclerosis predicts functional decline, respiratory symptom emergence, and survival#222370bioRxiv / medRxiv
• A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS#841713ClinicalTrials.gov
• Cervical Electrical Stimulation for ALS#899031ClinicalTrials.gov
• Digital Speech Markers for Monitoring ALS in Spanish Speakers#910250ClinicalTrials.gov
• Inspiratory Muscle Training With Powerbreath Device in Patients With ALS#917357ClinicalTrials.gov
• Peroxisome proliferator activator receptor gamma coactivator-1α overexpression in amyotrophic lateral sclerosis: A tale of two transgenics#1005406The University of Melbourne Library Digital Repository
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS#890215ClinicalTrials.gov
• Intranasal Dantrolene Nanoparticles for Treatment of Amyotrophic Lateral Sclerosis as a Disease-Modifying Drug#207048ScholarlyCommons at Penn
• Beyond the surface: Exploring differing aspects of wishes to hasten death in patients with amyotrophic lateral sclerosis.#232130NCBI PubMed Central
• Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD#234387ClinicalTrials.gov
• Troponin T and Neurofilament Light Chain Levels as Complementary Biomarkers of Disease Accumulation and Aggressiveness in Amyotrophic Lateral Sclerosis#290756bioRxiv / medRxiv
• Associations influencing quality of life in caregivers of patients with amyotrophic lateral sclerosis: a stress-process model approach.#312408NCBI PubMed Central
• Strenuous physical activity is associated with a younger age of amyotrophic lateral sclerosis onset in two independent cohorts.#396221NCBI PubMed Central
• A Study of Ranolazine in ALS#801194ClinicalTrials.gov
• Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients#855812ClinicalTrials.gov
• MIROCALS: Modifying Immune Response and OutComes in ALS#859294ClinicalTrials.gov
• Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients#859520ClinicalTrials.gov
• Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)#898919ClinicalTrials.gov
• Study of Predictive Factors of Progression of Motor Neurone Disease#906545ClinicalTrials.gov
• Ultra-high-caloric, Fatty Diet in ALS#906789ClinicalTrials.gov
• Factors Associated With Success of NIPPV in ALS Patients#919086ClinicalTrials.gov
• Quantitative Gait Analysis Reveals Distinct Patterns Associated With Pyramidal Involvement in Amyotrophic Lateral Sclerosis: A Cross-Sectional Study.#209388NCBI PubMed Central